ReviewJournal of clinical hypertension (Greenwich, Conn.)2007
Cardiovascular morbidity and mortality in high-risk populations: epidemiology and opportunities for risk reduction.
Review in Journal of clinical hypertension (Greenwich, Conn.), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 26 citations in OpenAlex.
- Impact of exercise and dietary fatty acid composition from a high-fat diet on markers of hunger and satiety.Appetite · 2011Trial
- Effectiveness of a Participatory Program for Improving the Cardiovascular and Cerebrovascular Health of Older Farmers in Rural Korea.International journal of environmental research and public health · 2023Article
- Results of a prospective cardiovascular disease prevention program.Preventive medicine reports · 2021Article
- Article
- Review
- Review the key role of self-efficacy in diabetes care.Journal of education and health promotion · 2013Review
- Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study.Clinics (Sao Paulo, Brazil) · 2013Article
- Cardiovascular risk factors in children and adolescents living in an urban area of Southeast of Brazil: Ouro Preto Study.European journal of pediatrics · 2009Article
- Effects of dietary fatty acid composition on 24-h energy expenditure and chronic disease risk factors in men.The American journal of clinical nutrition · 2009Article
- The Pol-e-pill finally arrives.Diabetes · 2008Article
Corrections and comments
- Commented on by
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite significant growth in the number of drug classes and individual agents available to combat various cardiovascular (CV) risk factors in clinical practice, the prevalence of these risk factors, including hypertension, diabetes mellitus, and obesity, has remained largely unchanged and in some cases has even increased during the past decade. CV risk factors remain consistently undertreated across the world, despite consensus guidelines issued by national and international health care organizations. Given the earlier onset of obesity and diabetes mellitus in many national populations, beginning from childhood, it is desirable to implement a range of lifestyle and pharmacologic interventions intended to modify CV risk factors while also improving glucose tolerance. Drugs that block the renin-angiotensin system are associated with reduced incidence of diabetes compared with other antihypertensive agents and should be considered mainstays of therapy for patients with hypertension who are at high risk for diabetes, CV disease, or both.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.